相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A pneumonia outbreak associated with a new coronavirus of probable bat origin
Peng Zhou et al.
NATURE (2020)
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Renhong Yan et al.
SCIENCE (2020)
A Genomic Perspective on the Origin and Emergence of SARS-CoV-2
Yong-Zhen Zhang et al.
CELL (2020)
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies
Daniel Wrapp et al.
CELL (2020)
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Yanling Wu et al.
CELL HOST & MICROBE (2020)
Probable Pangolin Origin of SARS-CoV-2 Associated with the COVID-19 Outbreak
Tao Zhang et al.
CURRENT BIOLOGY (2020)
Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential
Linlin Ma et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
Yan Wu et al.
SCIENCE (2020)
A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
Meng Yuan et al.
SCIENCE (2020)
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Jun Lan et al.
NATURE (2020)
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients' B Cells
Yunlong Cao et al.
CELL (2020)
A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2
Xiangyang Chi et al.
SCIENCE (2020)
Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
Alina Baum et al.
SCIENCE (2020)
The EMBL-EBI search and sequence analysis tools APIs in 2019
Fabio Madeira et al.
NUCLEIC ACIDS RESEARCH (2019)
Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy
Zongshu Xian et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
New therapies for acute RSV infections: where are we?
Ying Xing et al.
EUROPEAN JOURNAL OF PEDIATRICS (2019)
Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
Yushun Wan et al.
JOURNAL OF VIROLOGY (2019)
Nanobodies®† as inhaled biotherapeutics for lung diseases
Gino Van Heeke et al.
PHARMACOLOGY & THERAPEUTICS (2017)
Phase I Study of Ga-68-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma
Marleen Keyaerts et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Generation of Small Single Domain Nanobody Binders for Sensitive Detection of Testosterone by Electrochemical Impedance Spectroscopy
Guanghui Li et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Nanobody-derived nanobiotechnology tool kits for diverse biomedical and biotechnology applications
Yongzhong Wang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer
Isabel Van Audenhove et al.
EBIOMEDICINE (2016)
Antibody-dependent SARS coronavirus infection is mediated by antibodies against spike proteins
Sheng-Fan Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infection
Suzanne Willey et al.
RETROVIROLOGY (2011)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Antibody-dependent enhancement of Ebola virus infection
A Takada et al.
JOURNAL OF VIROLOGY (2003)
Lysine 322 in the human IgG3 CH2 domain is crucial for antibody dependent complement activation
JE Thommesen et al.
MOLECULAR IMMUNOLOGY (2000)
分享论文
